Changwan Ryu
Impact in
-
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Pulmonary Hypertension Research and Treatments
- Neonatal Respiratory Health Research
-
- Sarcoidosis and Beryllium Toxicity Research
Papers in
-
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 18
- Pulmonary Hypertension Research and Treatments 5
- Chronic Obstructive Pulmonary Disease (COPD) Research 3
- Physiology 12
- Sarcoidosis and Beryllium Toxicity Research 10
- Co-authors
- Erica L. Herzog (23 shared papers)Mridu Gulati (10 shared papers)Naftali Kaminski (9 shared papers)Robert Homer (6 shared papers)Hongyi Pan (5 shared papers)Jose D. Herazo‐Maya (5 shared papers)John Hwa (2 shared papers)Danielle Antin‐Ozerkis (3 shared papers)
- Journals
- CHEST Journal (5 papers)American Journal of Physiology-Lung Cellular and Molecular Physiology (4 papers)Respirology (2 papers)Arthritis & Rheumatology (1 paper)Medicine (1 paper)
- Partner nations
- United StatesBrazilSouth Korea
In The Last Decade
Changwan Ryu
32 papers receiving 649 citations
Peers
Comparison fields: 5 of 88
- Pulmonary and Respiratory Medicine 345
- Physiology 162
- Immunology 93
- Rheumatology 64
- Neurology 52
Countries citing papers authored by Changwan Ryu
This map shows the geographic impact of Changwan Ryu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Changwan Ryu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Changwan Ryu more than expected).
Fields of papers citing papers by Changwan Ryu
This network shows the impact of papers produced by Changwan Ryu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Changwan Ryu. The network helps show where Changwan Ryu may publish in the future.
Co-authors
The 25 scholars most cited alongside Changwan Ryu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 82 | |
| 2 | 2019 | 73 | |
| 3 | 2019 | 63 | |
| 4 | 2022 | 62 | |
| 5 | 2021 | 52 | |
| 6 | 2020 | 48 | |
| 7 | 2016 | 44 | |
| 8 | 2021 | 43 | |
| 9 | 2004 | 42 | |
| 10 | 2024 | 25 | |
| 11 | 2022 | 19 | |
| 12 | 2021 | 15 | |
| 13 | 2018 | 13 | |
| 14 | 2020 | 10 | |
| 15 | 2018 | 9 | |
| 16 | 2021 | 8 | |
| 17 | 2019 | 8 | |
| 18 | 2021 | 5 | |
| 19 | 2017 | 5 | |
| 20 | 2015 | 4 |
About Changwan Ryu
Changwan Ryu is a scholar working on Pulmonary and Respiratory Medicine, Physiology, Molecular Biology, Epidemiology and Surgery, having authored 35 papers that have together received 655 indexed citations. Recurring topics across this work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (18 papers), Sarcoidosis and Beryllium Toxicity Research (10 papers), Pulmonary Hypertension Research and Treatments (5 papers), Systemic Sclerosis and Related Diseases (3 papers), Sinusitis and nasal conditions (3 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (3 papers), Long-Term Effects of COVID-19 (2 papers) and Wnt/β-catenin signaling in development and cancer (2 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (345 citations), Physiology (162 citations), Immunology (93 citations), Rheumatology (64 citations) and Neurology (52 citations). Changwan Ryu has collaborated with scholars based in United States, Brazil and South Korea. Frequent co-authors include Erica L. Herzog, Mridu Gulati, Naftali Kaminski, Robert Homer, Hongyi Pan, Jose D. Herazo‐Maya, John Hwa, Danielle Antin‐Ozerkis, Inderjit Singh and Aglaia Ntokou. Their work appears in journals such as CHEST Journal, American Journal of Physiology-Lung Cellular and Molecular Physiology, Respirology, Arthritis & Rheumatology and Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.